Recent Posts

1. 

   Layoffs

   Oh, I'm just here for the schadenfreude ...but if it makes you feel better, I still own TAK stock which is totally in the crapper. So, thanks!

   Takeda

   anonymous

   Apr 25, 2024 at 6:29 PM

2. 

   Sell Otezla and Keep Sotyktu?

   Terrible decision. I left Celgene once Amgen puts their KPI claws in, but I am still in derm. Granted, I am now device, but I can say my old customers of 20+ years were disgusted with the attacks on their baby. It's not as if they know it...

   Bristol-Myers Squibb

   anonymous

   Apr 25, 2024 at 6:26 PM

3. 

   European Commission approves Astellas’ drug for expanded prostate cancer Treatment

   via On April 24, Astellas Pharma Inc. revealed that XTANDI enzalutamide) has received a label extension from the European Commission, marking it as the inaugural and only novel hormone therapy endorsed for high-risk biochemical recurrent...

   Pharma/Biotech Companies - In the News

   cafead

   Apr 25, 2024 at 6:22 PM

4. 

   Astrazeneca Tattoo Policy?

   Some dumb ass with barbed wire on their arm or a dolphin on their ass isn’t diversity sweetie.

   AstraZeneca

   anonymous

   Apr 25, 2024 at 6:15 PM

5. 

   Plan for contract reps for CVRM?

   The plan is to lay the contract folks off before the contract is over. Anything else you’ve heard is false

   AstraZeneca

   anonymous

   Apr 25, 2024 at 6:10 PM

6. 

   DL

   There’s nothing to give you ingrate. Stop looking for a hand out . Your attitude gives the working rank and file sales team a bad look

   Bio Reference

   anonymous

   Apr 25, 2024 at 6:09 PM

7. 

   Airsupra Goals Q2 - you’ll Crap Your Pants

   All these comments must be from people who are new to the industry and don’t understand how it works. Y’all didn’t say anything when 75% of the sales force blew away the Q1 goals

   AstraZeneca

   anonymous

   Apr 25, 2024 at 6:08 PM

8. + Show More